Cargando…
PW02-027 - CAPS and cost-effectiveness analysis project
Autores principales: | Alberighi, O Della Casa, Accame, L, Frenkel, J, Gattorno, M, Martini, A, Neven, B, Quartier, P, Pierotti, F, Turchetti, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952515/ http://dx.doi.org/10.1186/1546-0096-11-S1-A168 |
Ejemplares similares
-
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
por: Trieste, L, et al.
Publicado: (2015) -
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS)
por: Della Casa Alberighi, O, et al.
Publicado: (2015) -
PW02-037 - The Eurofever cohort of 136 patients with CAPS
por: Levy, R, et al.
Publicado: (2013) -
PW02-009 - PAPA syndrome: results from the Euroefever registry
por: Caorsi, R, et al.
Publicado: (2013) -
PW02-034 - NLRP3 mosaicism detection in CAPS using NGS
por: Stoffels, M, et al.
Publicado: (2013)